Junsheng Fan
Shanghai, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 20 publications
Clinical Analysis of Pulmonary Nontuberculous Mycobacterial Infection in Patients With Pre-Existing Stage II-IV Lung Cancer.
Journal: Clinical and experimental pharmacology & physiology
Published: June 30, 2025
NucS Thr74Ile confers mutator phenotype in a globally disseminated clinical Mycobacterium abscessus subsp. abscessus clone.
Journal: International journal of antimicrobial agents
Published: May 30, 2025
An enoyl-ACP reductase inhibitor, NITD-916, expresses anti-Mycobacterium abscessus activity.
Journal: Antimicrobial agents and chemotherapy
Published: May 23, 2025
The Rough Morphotype of Mycobacterium abscessus Enhances Its Virulence Through ROS/p65/NLRP3/GSDMD-Mediated Macrophage Pyroptosis.
Journal: Clinical and experimental pharmacology & physiology
Published: January 23, 2025
LeuRS-Targeting Prodrug, MRX-5, Expresses Anti-Mycobacterium abscessus Activity.
Journal: Clinical and experimental pharmacology & physiology
Published: December 25, 2024
TBAJ-587, a novel diarylquinoline, is active against Mycobacterium abscessus.
Journal: Antimicrobial agents and chemotherapy
Published: October 29, 2024
FL058, a novel β-lactamase inhibitor, increases the anti-Mycobacterium abscessus activity of imipenem.
Journal: International journal of antimicrobial agents
Published: August 09, 2024
GlnR activated transcription of nitrogen metabolic pathway genes facilitates biofilm formation by mycobacterium abscessus.
Journal: International journal of antimicrobial agents
Published: June 12, 2023
sRNA21, a novel small RNA, protects Mycobacterium abscessus against oxidative stress.
Journal: The journal of gene medicine
Published: January 07, 2023
Sitafloxacin Expresses Potent Anti-Mycobacterium abscessus Activity.
Journal: Frontiers in microbiology
Published: September 19, 2021
A Novel Oxazolidinone, Contezolid (MRX-I), Expresses Anti-Mycobacterium abscessus Activity In Vitro.
A Novel Oxazolidinone, Contezolid (MRX-I), Expresses Anti-Mycobacterium abscessus Activity In Vitro.
Journal: Antimicrobial agents and chemotherapy
Published: August 30, 2021
Last Updated: 09/26/2026